Kliniken & Institute ... Kliniken Chirurgische Klinik... Allgemein-, Viszeral-... Forschung Pankreasforschung Sektion... AG Molekulare... Publikationen Übersichtsartikel


Herr I, Lozanovski V, Houben P, Schemmer P, Büchler MW (2013). Sulforaphane and related mustard oils in focus of cancer prevention and therapy. Wiener Med. Wochenschrift, 163, 80-88.

Herr I, Moldenhauer G (2012). EpCAMxCD3 specific antibody combined with TRAIL-lymphocytes as new therapeutic tool for enhanced anti-tumor responses. OncoImmunology, 1, 741-743.

Zhou W, Lv R, Wang X, Mou Y, Cai X, Herr I (2010). Stapler vs suture closure of pancreatic remnant after distal pancreatectomy: a meta-analysis. Am J Surgery., 200, 529-36. 

Herr I, Büchler MW (2010). Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat Rev., 36, 377-83. 

Apel A, Zentgraf H, Büchler MW, Herr I (2009). Autophagy – a double edged sword in oncology. Int J. Cancer, 125, 991-995. 

Herr I, Gassler N, Friess H and Büchler MW (2007). Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis, 2, 271-291. 

Herr I, Schemmer P and Büchler MW. (2007). On the TRAIL to therapeutic intervention in liver disease. Hepatology, 46, 266-274.

Herr I, Groth A, Schemmer P and Büchler MW (2007). Adult stem cells in progression and therapy of hepatocellular carcinoma. Int. J. Cancer, 121, 1875-1882. 

Mattern J, Büchler MW and Herr I (2007). Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy. Cancer Biol. Ther, 6, 1345-54.

Herr I and Pfitzenmaier J (2006). Glucocorticoid use in prostate cancer and other solid tumors: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncology, 7, 425-426.

Herr I and Büchler MW (2006). New in vivo results support concerns about harmful effects of cortisone drugs in the treatment of breast cancer. Cancer Biol. Ther. 8, 941-942. 

Rutz HP and Herr I (2005). Glucocorticoid administration in antiemetic therapy: is it safe? Cancer, 15, 2656-2657. 

Herr I and Marme A (2005). Glucocorticoids and progression of breast cancer. Cancer Biol. Ther. 4(12). 

Rutz HP and Herr I (2004). Interference of glucocorticoids with apoptosis signaling and host-tumor interactions. Cancer Biol. Ther. 3, e32-e35. 

Herr I and Debatin K-M (2001). Cellular stress response and apoptosis in cancer therapy. Blood, 98, 2603-2614. 

Debatin K-M, Beltinger C, Boehler, T, Fellenberg, J, Friesen, C, Fulda S, Herr I, Los M, Scheuerpflug C and Sieverts H (1997). Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction. Biochem. Soc. T. 25,405-410.

Wilhelm D, van Dam H, Herr I, Baumann B, Herrlich P and Angel P (1995). Both ATF-2 and cJun are phosphorylated by stress-activated protein kinases in response to UV irradiation. Immunobiology 193, 143-148.